Market Cap ₹214 Cr.
Stock P/E -4.3
P/B -1.6
Current Price ₹163
Book Value ₹ -99.5
Face Value 10
52W High ₹266
Dividend Yield 0%
52W Low ₹ 100.1
Caprihans India Ltd is a leading Indian company engaged in the manufacturing and distribution of a wide range of packaging and specialty films. With its headquarters in Mumbai, India, Caprihans has established itself as a prominent player in the packaging industry since its inception in 1949. The company specializes in the production of PVC films, which find applications in diverse sectors such as pharmaceuticals, food and beverages, stationery, and more. Caprihans' product portfolio includes rigid PVC films, flexible PVC films, and laminated PVC films, catering to the varying needs of its customers. Caprihans India Ltd has a robust manufacturing infrastructure, incorporating state-of-the-art technologies to ensure superior quality and performance of its products. The company has a wide distribution network that enables it to serve a large customer base both domestically and internationally. Driven by innovation, quality, and customer satisfaction, Caprihans India Ltd continues to strengthen its position as a trusted and reliable provider of packaging solutions in India and beyond.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Jun 2022 | Sep 2022 | Dec 2022 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 88 | 87 | 93 | 99 | 239 | 240 | 231 | 171 | 179 | 163 |
Other Income | 1 | 1 | 1 | 1 | 5 | 5 | -1 | 5 | 4 | 4 |
Total Income | 89 | 88 | 94 | 100 | 244 | 245 | 230 | 176 | 183 | 167 |
Total Expenditure | 79 | 80 | 90 | 93 | 224 | 226 | 220 | 157 | 161 | 146 |
Operating Profit | 10 | 8 | 4 | 7 | 20 | 19 | 10 | 19 | 22 | 21 |
Interest | 0 | 0 | 0 | 0 | 16 | 16 | 16 | 20 | 20 | 21 |
Depreciation | 1 | 1 | 1 | 1 | 8 | 9 | 9 | 10 | 10 | 10 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 7 | -2 | 0 | -2 | 0 |
Profit Before Tax | 9 | 7 | 3 | 6 | -4 | 1 | -17 | -11 | -10 | -10 |
Provision for Tax | 2 | 2 | 1 | 1 | 1 | 2 | -0 | -0 | -0 | 4 |
Profit After Tax | 7 | 5 | 2 | 5 | -5 | -1 | -16 | -11 | -9 | -14 |
Adjustments | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 7 | 5 | 2 | 5 | -5 | -1 | -16 | -11 | -9 | -14 |
Adjusted Earnings Per Share | 5.6 | 3.8 | 1.4 | 3.8 | -3.8 | -0.8 | -12.4 | -8.1 | -7.2 | -10.4 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 221 | 242 | 253 | 239 | 233 | 249 | 269 | 289 | 297 | 798 | 936 | 744 |
Other Income | 3 | 4 | 4 | 5 | 4 | 3 | 4 | 5 | 8 | 11 | 11 | 12 |
Total Income | 224 | 246 | 257 | 244 | 237 | 252 | 272 | 294 | 304 | 809 | 948 | 756 |
Total Expenditure | 210 | 234 | 242 | 223 | 220 | 242 | 264 | 278 | 274 | 740 | 876 | 684 |
Operating Profit | 14 | 12 | 15 | 22 | 16 | 10 | 9 | 17 | 30 | 69 | 71 | 72 |
Interest | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 69 | 60 | 77 |
Depreciation | 3 | 4 | 3 | 4 | 3 | 3 | 3 | 4 | 4 | 34 | 33 | 39 |
Exceptional Income / Expenses | 0 | 0 | 0 | -7 | 2 | 0 | 0 | 0 | 0 | 0 | 127 | -4 |
Profit Before Tax | 10 | 8 | 11 | 11 | 15 | 6 | 5 | 12 | 26 | -34 | 105 | -48 |
Provision for Tax | 4 | 3 | 4 | 5 | 5 | 2 | 1 | 3 | 6 | 6 | 34 | 4 |
Profit After Tax | 7 | 5 | 7 | 5 | 10 | 4 | 4 | 9 | 20 | -40 | 72 | -50 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 7 | 5 | 7 | 5 | 10 | 4 | 4 | 9 | 20 | -40 | 72 | -50 |
Adjusted Earnings Per Share | 5.2 | 4 | 5.4 | 4.1 | 7.3 | 3.2 | 2.8 | 7 | 15.4 | -30.1 | 54.6 | -38.1 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 17% | 48% | 30% | 16% |
Operating Profit CAGR | 3% | 61% | 48% | 18% |
PAT CAGR | 0% | 100% | 78% | 26% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 53% | 11% | 25% | 14% |
ROE Average | 0% | 5% | 5% | 5% |
ROCE Average | 35% | 22% | 16% | 12% |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 106 | 109 | 113 | 120 | 128 | 129 | 131 | 139 | 159 | -305 | 539 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 529 | 531 |
Other Non-Current Liabilities | 2 | 2 | 1 | -1 | -1 | -1 | -1 | -1 | -1 | 17 | 35 |
Total Current Liabilities | 32 | 34 | 55 | 41 | 26 | 33 | 30 | 42 | 42 | 612 | 316 |
Total Liabilities | 140 | 145 | 170 | 160 | 153 | 161 | 160 | 179 | 200 | 853 | 1421 |
Fixed Assets | 20 | 17 | 16 | 16 | 16 | 19 | 21 | 20 | 20 | 456 | 1029 |
Other Non-Current Assets | 4 | 5 | 7 | 10 | 6 | 7 | 7 | 6 | 6 | 8 | 83 |
Total Current Assets | 116 | 123 | 147 | 134 | 130 | 136 | 133 | 154 | 174 | 389 | 309 |
Total Assets | 140 | 145 | 170 | 160 | 153 | 161 | 160 | 179 | 200 | 853 | 1421 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 12 | 17 | 8 | 15 | 9 | 13 | 4 | 6 | 5 | 14 | 9 |
Cash Flow from Operating Activities | 10 | 7 | 14 | 15 | -8 | 1 | -3 | 10 | 8 | 10 | -53 |
Cash Flow from Investing Activities | -3 | -1 | -4 | -18 | 14 | -7 | 9 | -9 | 1 | 1 | -38 |
Cash Flow from Financing Activities | -2 | -2 | -3 | -3 | -3 | -3 | -3 | -2 | -1 | -15 | 89 |
Net Cash Inflow / Outflow | 5 | 3 | 7 | -6 | 4 | -9 | 3 | -1 | 9 | -4 | -2 |
Closing Cash & Cash Equivalent | 17 | 21 | 15 | 9 | 13 | 4 | 6 | 5 | 14 | 9 | 7 |
# | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 5.17 | 4 | 5.37 | 4.15 | 7.35 | 3.15 | 2.79 | 7 | 15.4 | -30.13 | 54.64 |
CEPS(Rs) | 7.79 | 6.69 | 7.99 | 6.83 | 9.96 | 5.73 | 5.34 | 9.9 | 18.15 | -4.19 | 79.98 |
DPS(Rs) | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 0.75 | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 80.53 | 82.78 | 86.09 | 91.43 | 97.08 | 98.51 | 99.48 | 105.48 | 121.03 | -232.25 | -73.58 |
Core EBITDA Margin(%) | 4.44 | 2.98 | 3.88 | 6.25 | 4.95 | 2.51 | 1.9 | 4.01 | 7.6 | 7.25 | 6.37 |
EBIT Margin(%) | 4.29 | 3.05 | 4.04 | 4.35 | 5.96 | 2.47 | 1.96 | 4.39 | 9 | 4.33 | 17.46 |
Pre Tax Margin(%) | 4.29 | 3.05 | 3.92 | 4.06 | 5.76 | 2.27 | 1.7 | 4.11 | 8.7 | -4.19 | 11.16 |
PAT Margin (%) | 2.81 | 1.98 | 2.54 | 2.08 | 3.77 | 1.61 | 1.35 | 3.15 | 6.78 | -4.91 | 7.6 |
Cash Profit Margin (%) | 4.23 | 3.31 | 3.79 | 3.42 | 5.11 | 2.92 | 2.59 | 4.46 | 7.99 | -0.68 | 11.13 |
ROA(%) | 5.01 | 3.68 | 4.48 | 3.3 | 6.17 | 2.64 | 2.28 | 5.42 | 10.66 | -7.51 | 6.31 |
ROE(%) | 6.56 | 4.9 | 6.36 | 4.67 | 7.8 | 3.22 | 2.82 | 6.83 | 13.6 | 0 | 0 |
ROCE(%) | 10.04 | 7.56 | 10.09 | 9.8 | 12.32 | 4.94 | 4.08 | 9.51 | 18.06 | 13 | 35.29 |
Receivable days | 87.21 | 82.7 | 77.68 | 78.75 | 75.07 | 82.48 | 92.37 | 88.96 | 88.93 | 63.74 | 74.62 |
Inventory Days | 43.36 | 44.34 | 42.25 | 45.34 | 52.47 | 53.26 | 51.35 | 57.37 | 68.02 | 43.28 | 42.1 |
Payable days | 34.88 | 37.13 | 48.65 | 76.31 | 68.27 | 52.36 | 53.26 | 59.99 | 65.05 | 58 | 77.16 |
PER(x) | 7.49 | 9.82 | 12.37 | 19.28 | 13.4 | 27.82 | 21.54 | 4.4 | 5.25 | 0 | 2.1 |
Price/Book(x) | 0.48 | 0.47 | 0.77 | 0.87 | 1.01 | 0.89 | 0.6 | 0.29 | 0.67 | -0.53 | -1.56 |
Dividend Yield(%) | 3.87 | 3.82 | 2.26 | 1.88 | 1.52 | 1.71 | 1.25 | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 0.15 | 0.13 | 0.22 | 0.28 | 0.42 | 0.36 | 0.22 | 0.04 | 0.23 | 1.02 | 0.84 |
EV/Core EBITDA(x) | 2.42 | 2.65 | 3.84 | 3.09 | 5.89 | 9.08 | 6.94 | 0.78 | 2.24 | 11.8 | 11.09 |
Net Sales Growth(%) | 13.18 | 9.69 | 4.48 | -5.48 | -2.48 | 6.79 | 8.09 | 7.63 | 2.46 | 169.19 | 17.3 |
EBIT Growth(%) | -2.7 | -22 | 38.04 | 2.06 | 33.47 | -58.38 | -16.44 | 141.26 | 110.02 | 29.78 | 372.77 |
PAT Growth(%) | -4.87 | -22.63 | 34.22 | -22.77 | 77.23 | -57.1 | -11.56 | 151.17 | 119.9 | -295.67 | 281.34 |
EPS Growth(%) | -4.87 | -22.63 | 34.22 | -22.77 | 77.23 | -57.1 | -11.56 | 151.17 | 119.9 | -295.67 | 281.34 |
Debt/Equity(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.24 | -6.76 |
Current Ratio(x) | 3.6 | 3.61 | 2.66 | 3.25 | 5.08 | 4.1 | 4.37 | 3.69 | 4.12 | 0.64 | 0.98 |
Quick Ratio(x) | 2.74 | 2.53 | 2.16 | 2.33 | 3.68 | 2.91 | 3.15 | 2.37 | 2.79 | 0.42 | 0.72 |
Interest Cover(x) | 3464.57 | 2384.56 | 35.02 | 14.73 | 29.18 | 12.64 | 7.7 | 15.98 | 29.75 | 0.51 | 2.77 |
Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.22 | 4.33 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 71.66 | 71.66 | 71.66 | 71.66 | 51 | 51 | 51 | 51 | 51 | 51 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 1.97 | 0.04 | 0.04 | 0.04 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
Public | 26.37 | 28.3 | 28.3 | 28.3 | 48.98 | 48.98 | 48.98 | 48.98 | 48.98 | 48.98 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 0.94 | 0.94 | 0.94 | 0.94 | 0.67 | 0.67 | 0.67 | 0.67 | 0.67 | 0.67 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 0.35 | 0.37 | 0.37 | 0.37 | 0.64 | 0.64 | 0.64 | 0.64 | 0.64 | 0.64 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1.31 | 1.31 | 1.31 | 1.31 | 1.31 | 1.31 | 1.31 | 1.31 | 1.31 | 1.31 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About